China National Accord Medicines Corp Ltd Financial Flexibility Index
China National Accord Medicines Corp Ltd financial flexibility index. China National Accord Medicines Corp Ltd (200028) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of HK$-364.00 Million (operating CF HK$-424.00 Million minus capex HK$60.00 Million) represents 0% of total liabilities (HK$29.01 Billion). See cash generation quality of China National Accord Medicines Corp Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of China National Accord Medicines Corp Ltd (1998–2025)
Financial flexibility index of China National Accord Medicines Corp Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for China National Accord Medicines Corp Ltd across 28 annual periods. Check China National Accord Medicines Corp Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
China National Accord Medicines Corp Ltd Financial Flexibility Index by Year (1998–2025)
China National Accord Medicines Corp Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for China National Accord Medicines Corp Ltd. For the full cash flow conversion analysis, see cash flow conversion of China National Accord Medicines Corp Ltd.
| Year | Flexibility Index | Free Cash Flow (HKD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | HK$1.86 Billion | HK$1.64 Billion | HK$27.47 Billion | ▼ -49.1% |
| 2024 | 0.13x | HK$3.55 Billion | HK$3.27 Billion | HK$26.80 Billion | ▲ +8.2% |
| 2023 | 0.12x | HK$3.26 Billion | HK$2.94 Billion | HK$26.59 Billion | ▼ -1.5% |
| 2022 | 0.12x | HK$2.88 Billion | HK$2.56 Billion | HK$23.17 Billion | ▲ +52.1% |
| 2021 | 0.08x | HK$2.03 Billion | HK$1.66 Billion | HK$24.76 Billion | ▲ +3.4% |
| 2020 | 0.08x | HK$1.80 Billion | HK$1.50 Billion | HK$22.71 Billion | ▼ -36.0% |
| 2019 | 0.12x | HK$2.25 Billion | HK$2.00 Billion | HK$18.16 Billion | ▲ +17.7% |
| 2018 | 0.11x | HK$1.58 Billion | HK$1.32 Billion | HK$15.02 Billion | ▼ -12.5% |
| 2017 | 0.12x | HK$1.49 Billion | HK$1.29 Billion | HK$12.42 Billion | ▼ -14.4% |
| 2016 | 0.14x | HK$1.74 Billion | HK$1.47 Billion | HK$12.40 Billion | ▼ -13.4% |
| 2015 | 0.16x | HK$1.24 Billion | HK$1.05 Billion | HK$7.65 Billion | ▲ +384.4% |
| 2014 | -0.06x | HK$-454.03 Million | HK$-796.70 Million | HK$7.98 Billion | ▼ -180.8% |
| 2013 | 0.07x | HK$615.52 Million | HK$465.03 Million | HK$8.74 Billion | ▲ +1.5% |
| 2012 | 0.07x | HK$517.53 Million | HK$323.96 Million | HK$7.46 Billion | ▲ +1.6% |
| 2011 | 0.07x | HK$426.29 Million | HK$227.32 Million | HK$6.24 Billion | ▼ -41.7% |
| 2010 | 0.12x | HK$606.15 Million | HK$428.16 Million | HK$5.18 Billion | ▲ +36.5% |
| 2009 | 0.09x | HK$373.78 Million | HK$270.85 Million | HK$4.36 Billion | ▼ -21.5% |
| 2008 | 0.11x | HK$331.56 Million | HK$246.58 Million | HK$3.03 Billion | ▲ +64.0% |
| 2007 | 0.07x | HK$159.11 Million | HK$87.70 Million | HK$2.39 Billion | ▼ -51.0% |
| 2006 | 0.14x | HK$299.95 Million | HK$181.73 Million | HK$2.21 Billion | ▼ -53.6% |
| 2005 | 0.29x | HK$198.90 Million | HK$148.28 Million | HK$678.73 Million | ▼ -1.0% |
| 2004 | 0.30x | HK$144.48 Million | HK$130.30 Million | HK$487.99 Million | ▲ +50.9% |
| 2003 | 0.20x | HK$130.58 Million | HK$81.22 Million | HK$665.47 Million | ▲ +153.1% |
| 2002 | 0.08x | HK$55.66 Million | HK$28.76 Million | HK$717.90 Million | ▼ -45.4% |
| 2001 | 0.14x | HK$107.06 Million | HK$71.16 Million | HK$753.72 Million | ▼ -58.7% |
| 2000 | 0.34x | HK$29.53 Million | HK$8.52 Million | HK$85.83 Million | ▼ -40.8% |
| 1999 | 0.58x | HK$50.38 Million | HK$22.84 Million | HK$86.72 Million | ▲ +325.2% |
| 1998 | 0.14x | HK$15.59 Million | HK$5.21 Million | HK$114.11 Million | — |